The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis.

Saved in:
Bibliographic Details
Title: The Status and Future Directions of Treatments for Polyglutamine Spinocerebellar Ataxia: A Bibliometric and Visual Analysis.
Authors: Ding S; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Peng L; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Department of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China., Chen Z; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Bioinformatics Center and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China., Dong M; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Tang C; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Gong Y; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., He L; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Wu Q; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China., Qiu R; School of Computer Science and Engineering, Central South University, Changsha, China., Jiang H; Department of Neurology, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Bioinformatics Center and National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.; Hunan International Scientific and Technological Cooperation Base of Neurodegenerative and Neurogenetic Diseases, Changsha, China.; Department of Neurology, The Third Xiangya Hospital of Central South University, Changsha, Hunan, 410008, China.; Key Laboratory of Hunan Province in Neurodegenerative Disorders, Central South University, Changsha, Hunan, 410008, China.; National International Collaborative Research Center for Medical Metabolomics, Central South University, Changsha, Hunan, China.; Furong Laboratory, Central South University, Changsha, Hunan, 410008, China.; Brain Research Center, Central South University, Changsha, Hunan, 410008, China.
Source: Current neuropharmacology [Curr Neuropharmacol] 2026; Vol. 24 (1), pp. 95-120.
Publication Type: Journal Article; Review
Journal Info: Publisher: Bentham Science Publishers Country of Publication: United Arab Emirates NLM ID: 101157239 Publication Model: Print Cited Medium: Internet ISSN: 1875-6190 (Electronic) Linking ISSN: 1570159X NLM ISO Abbreviation: Curr Neuropharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1875-6190
DOI:10.2174/011570159X360111250502055242